与「AI-healthcare」相关的搜索结果

Healthcare AI is not just a model question. It is a control question. As AI enters clinical workflows, hospitals need to know where patient data goes, who governs it, and whether they can deploy AI on their own terms. That is why control, security, and flexibility matter.

Beyond image generation, we know people want more from AI like healthcare improvements and scientific discovery. Compute is how we get it. If America doesn't build it, others will.

Super excited to announce seven new world-class MAI models today. They represent what we consider a new era in AI designed to keep you in control and on the frontier. First is our text foundation model, MAI-Thinking-1, exceptionally strong on reasoning and SWE tasks. - It’s a 35B active parameter MoE with a 256K context window. Independent human raters on Surge prefer it for overall quality in blind side-by-sides versus Sonnet 4.6, and it’s achieved 97% on AIME 2025, the key measure of its general-purpose reasoning abilities. - It's at 53% on SWE Bench Pro, placing it right alongside Opus 4.6 on one of the toughest coding benchmarks. - And since we co-designed our models with our own silicon, MAI-Thinking-1 is optimized on our MAIA 200 chip. Benchmarking head-to-head against the GB200, we see 30% better performance per dollar as well as a 1.4x performance-per-watt gain when running our MAI models on the MAIA 200 end-to-end. Next is MAI-Image-2.5 and its Flash variant. Two super strong models now at #2# on the leaderboards, surpassing the score of Nano Banana 2 on image editing. Last for now is MAI-Code-1-Flash, our new inference efficient coding model, especially tuned for VS Code and GitHub Copilot CLI. - Code-1-Flash achieves 51% on SWE Bench Pro, despite having just 5B parameters, putting it closer to Haiku in size but cheaper in cost. All of this is the foundation for Microsoft Frontier Tuning. It lets you customize our models to create custom, company-specific agents that only you control. You can make our model, your model. Your data. Your agents. Your moat. Early adopters are already seeing a difference. When we tuned our models for McKinsey’s tasks, MAI delivered the highest win rate, outperforming GPT-5.5 on quality, while being 10x lower on cost. Also really excited to be collaborating with the amazing team at Mayo Clinic to jointly train a new frontier AI model for healthcare. Our announcements today mark another milestone on the road to humanist superintelligence. You can learn more and about our other new models in our latest blog:

The past couple months we may be witnessing what the Applied AI layer will look like at scale. Despite some of the initial critique that this would just be a thin layer on the LLM, it’s turning out that actually driving agentic workflows in an enterprise is far more complex. And anywhere there’s complexity you generally gain a moat and value over time. Here are a few of the components that appear to make up the playbook based on the examples we’re collectively seeing in coding, legal, healthcare, customer support, financial services and other fields: * Build the features that bridge the gap between the intelligence and the workflow. Some workflows can be automated by simply going to a general purpose interface, but others need tuned interfaces and features tied to the work they’re augmenting or automating. They need features that are specific to capturing the kind of data that’s needed as context for the agent. And they need a variety of bespoke tools for the agent to use, and unique interfaces for the human-in-the-loop UX. Going far deeper than just presenting the output tokens is clearly critical, and the more depth there is here definitionally the more sustaining value. * Act as the model router balancing frontier intelligence with cheaper models. A natural advantage that any model neutral platform has is that it can naturally (in a business model-aligned way) leverage whatever level of intelligence is necessary for the workflows they’re automating to get done. There are plenty of scenarios where you need GPT-5.5 or Fable level capability, and also lots of workloads where a more efficient closed or open weights do the trick. Only the companies that have deep evals on specific tasks across all models, and the ability business model wise to leverage them, are in a great position. * Drive the actual implementation and change management via FDE or equivalent. A big reason the applied layer works at scale is that most enterprises need some degree of help and support with change management in implementing agents for their workflows. Data has to be cleaned up and moved to modern systems, processes have to be re-engineered and documented, workflows have to be evaled, SLAs have to get achieved, and so on. All of this is going to be unique for every type of process that gets implemented, which means the companies that have expertise in a given domain and come with all the relevant best practices will be in a strong position. * Implement domain specific GTM that creates expertise in that field. Beyond FDEs the companies that can build sales and GTM motions aligned to their domains also have a natural advantage. Most IT and line of business leaders have too many things to do in any given day; so if you’re not on their agenda, likely someone else is. Depending on the industry, there are entirely different sets of language you use, ways of working through security and compliance, regulatory controls you have to support, industry events that companies convene at, different system integrator and consulting partners you need to work with, and so on. The more generalized this gets the less you can speak the customers language, which is where the applied layer has a leg up. A final note. There remains a view that a lot of this is all mitigated by model intelligence alone, and the bitter lesson solves all of this in the limit. That’s possibly true, but enterprises need help changing *today*. And many aspects of how to bring intelligence to real world work don’t only depend on the axis of the pure capability of the model, so most of what you’re doing now to win ends up being important no matter how good the models get.

Elon Musk: Optimus Will Be Bigger Than the iPhone At Tesla’s 2025 shareholder meeting, Elon Musk positioned Optimus, Tesla’s humanoid robot, as the biggest product launch of all time, larger than smartphones in impact and scale. He claims it will have the fastest production ramp of any complex manufactured product, targeting one million robots per year initially and scaling to ten million. His vision: every human will want a personal robot, with multiple industrial units for every household. Musk argues Optimus will surpass the best human surgeons in precision and perform procedures beyond human capability. Tesla’s real breakthrough isn’t the car; it’s positioning itself as a robotics and AI company reshaping labor and healthcare.

While showbiz bickers over AI video continuity glitches and educators remain stuck debating AI-generated PPTs, World Models are quietly disrupting non-tech sectors, igniting a radical paradigm shift in clinical medicine and surgical simulation. Why healthcare and not Hollywood? Because Hollywood demands visual perfection, but healthcare mandates absolute physical causality. Traditional medical AI could only act as a static periscope—pinpointing a lesion on an existing scan. Yet disease is inherently dynamic. When a physician prescribes a treatment, they historically lacked a patient-specific, long-term window into the exact downstream changes after the patient ingests the drug. Recent breakthroughs showcased at elite computing summits like ICCV have elevated medical AI from passive visual recognition to a predictive, generative "World Simulator" tailored for prognosis and treatment optimization. In validated clinical applications, this technology leverages potent counterfactual reasoning. Take transarterial chemoembolization (TACE) for liver cancer and advanced radiotherapy as prime examples: before finalizing an intervention, a Medical World Model (MeWM) ingests a patient’s current CT imagery to simulate months of dynamic disease progression within its latent space. It cross-aligns multimodal parameters to synthesize high-fidelity visual representations of post-treatment tumor trajectories. Simultaneously, its inverse dynamics model quantifies how varying embolic agents or drug cocktails shift long-term survival curves. Empirically, this "future-simulation" paradigm has propelled clinical decision success rates (F1-score) by 13%, cementing its role as an indispensable AI co-pilot. Today, multimodal medical models are rapidly embedding into hospital HIS/EMR nervous systems, as specialized prognosis simulators push past theoretical boundaries into raw performance validation. The ultimate utility of a World Model isn't coding text or animating fantasy; it is evolving into a rigorous, low-cost simulation infrastructure—serving as a high-stakes safeguard for human decision-making. 【The Grand Forecast】 The successful clinical deployment of Medical World Models proves their unique capacity to "simulate future outcomes before executing current actions." This technical paradigm—trading pure aesthetic appeal for rigid physical and biological causality—is sprawling beyond tech ecosystems at a breakneck speed. Stripping away healthcare, autonomous driving, and media entertainment, which trial-and-error heavy traditional industry do you predict World Models will infiltrate and disrupt next? Will it be macro-climate disaster modeling in modern agriculture, dynamic supply-chain evolution in urban planning, extreme stress-testing in deep-sea aerospace engineering, or an entirely unmapped frontier? Drop your sharpest thesis and reasoning in the comments below. Let’s chart the hidden industrial landscape of the next generation of World Models!

AI diagnostic tools are transforming #healthcare# by 2026, enhancing accuracy and speeding up detection, but they won’t replace #doctors# entirely. —  @meisshaily #ArtificialIntelligence# #Technology# #TechNews# #Tech# #AI# #Efficiency#

Rising healthcare and consumer stocks boosted the Dow to a record closing high, while the S&P 500 and the Nasdaq also inched into the green for record closes despite a pause in the AI rally. Read:

Rising healthcare and consumer stocks boosted the Dow to a record closing high, while the S&P 500 and the Nasdaq also inched into the green for record closes despite a pause in the AI rally